Novo Nordisk (NVO) stock is in focus as FDA declines a cancer drug approval for Incyte (INCY) and MacroGenics (MGNX) due to ...

Scholar Rock (NASDAQ:SRRK) executives said the company is “poised for a transformative year in 2026,” with its top priority ...

Ardena appoints Paul Edwards as chief people officer to strengthen organizational capability and supporting international growth: Ghent, Belgium Thursday, March 5, 2026, 14:30 Hrs ...

Our team is prepared to resubmit the upitigramab BLA following a successful FDA reinspection of the Catalent, Indiana ...

FDA reinspection, apitegromab BLA resubmission and 2026 launch outlook, plus cash and new debt facility—read now.

Ardena has appointed Paul Edwards as its new Chief People Officer (CPO). Edwards comes to Ardena following 16 years at ...

Ardena, a specialist pharmaceutical contract development and manufacturing organizatin (CDMO) and bioanalytical contract ...

Seres Therapeutics named former Merck leader Richard N. Kender as executive chair and interim CEO. Urgent care tech company Experity appointed Bobby Ghoshal as CEO. Dana Fox McInerney joined Trevi ...

Scholar Rock Holding Corp is set to report fourth-quarter results Tuesday before the market opens, with investors focused on the biotech’s cash position and regulatory progress as it prepares for a ...

Swiss contract development and manufacturing organisation (CDMO) Lonza Group AG plans to set up a global capability centre in ...

Major companies like Macy’s and Nestle have said they would be letting go of employees this month.

The $166 ​bln Wegovy maker has ⁠effectively shed all ​its share-price gains ​from a pioneering obesity drug. The key problem: ​failing to ​build a vast supply chain ‌for ⁠a remedy that could treat 1 ...